Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model

<div>(a) CFU harvested from the joint tissue (log scale). (b) CFU harvested from the implants (log scale).</div>

BioMed Research International

fig3

Figure 3

Figure 3: Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model 

Figure 3 | Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model 